Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Trends Biochem Sci. 2017 Sep 27;42(11):862–872. doi: 10.1016/j.tibs.2017.09.003

Table 1.

TEADs in disease

Disease Gene Alteration (mutation or expression) Effects Target gene Reference
Sveinsson’s chorioretinal atrophy TEAD1 Y421H inactivating mutation choroidal and retinal degeneration 14
Breast cancer, squamous cell carcinoma TEAD4 increased expression increased cell proliferation and tumorigenesis, decreased survival 42
Prostate cancer TEAD1 increased expression decreased survival 62
Breast cancer TEAD4 increased expression 63
Breast cancer TEAD2 increased expression EMT zyxin 65
Colorectal cancer TEAD2, TEAD4 increased expression EMT, correlated with decreased survival vimentin 66
Cervical cancer, breast cancer TEAD1 resistance to apoptosis livin 67
Pancreatic cancer TEAD1 increased expression mesothelin 68
Melanoma TEAD4 increased invasiveness, resistance to MAPK inhibition 69